(Press-News.org) Two studies published in BioMed Central's open access journal BMC Medicine examined the cost of delivering the human papillomavirus (HPV) vaccine to primary school girls in Tanzania. Both studies found that the cost of HPV vaccine delivery to adolescent girls may be substantially higher compared with the cost of delivering a new vaccine to an infant where the delivery schedule matches the existing infant immunization schedule.
Cervical cancer is the second largest cancer-related killer of women in the world, with half a million new cases of cervical cancer worldwide in 2008, and it is the most common cause of cancer-related deaths in women in Tanzania. The main cause of this cancer is carcinogenic HPV types. The introduction of HPV vaccination in Sub-Saharan Africa offers a new opportunity for cervical cancer control. The WHO recommends vaccinating 9-13 year old girls to protect against HPV types 16 and 18, which contribute to the development of over 70% of cervical cancers. In most low- and middle-income countries, however, the vaccine price being offered to the public, at US$6-130 per dose, has been a barrier for vaccine uptake. Fortunately, the GAVI-Alliance (Global Alliance for Vaccines and Immunizations) announced in November 2011 that it would move towards funding support for HPV vaccines for eligible countries. HPV vaccines could therefore become an option in many countries where they would otherwise be unaffordable.
Information is lacking on large-scale, country-wide implementation costs of vaccine delivery. With this in mind, in the first paper, lead author Wilm Quentin from the Technical University in Berlin, and co-authors from the London School of Hygiene & Tropical Medicine, the National Institute for Medical Research in Tanzania and the World Health Organization (WHO) estimated the costs of a school-based HPV vaccine project that compared two different vaccine delivery strategies: class-based and age-based vaccination with health centre vaccination for those that missed a dose at school[1]. This study was implemented in randomly selected schools across 3 districts in Tanzania. The study also modelled incremental scaled-up costs of a regional vaccination program. Quentin et al found that, in general, costs for class-based delivery rather than age-based delivery were lower, and the economic scaled-up costs for Tanzania's Mwanza region were an estimated US$1.3 million (approx. US$9.76 per fully immunized girl, excluding vaccine costs).
In a second study, Raymond Hutubessy from the WHO and colleagues tested WHO new Cervical Cancer Prevention and Control Costing (C4P) tool over a five-year planning period. This tool assists low-and middle-income countries with planning their HPV vaccine programs and estimates the incremental costs to the health system of vaccinating adolescent girls through schools, health facilities and outreach-based strategies. The most important costs of service delivery were social mobilization, education and communication and operational costs such as training, health personnel time, vaccination cards, stationery, supervision and monitoring. It was estimated that the vaccine could be delivered at US$12.40 per fully immunized girl in terms of economic costs, again excluding vaccine costs. The authors noted that, when countries expand their routine immunization schedules with new vaccines to new target populations, as is the case with HPV vaccine, they face initial start-up costs to fund pre-introduction activities such as training, not to mention ensuring that the vaccine is delivered on an ongoing basis. However, after introduction, costs would be cheaper and make HPV vaccination even more affordable. Hutubessy commented "These figures will enable governments to plan ahead so that they can adequately secure the financial resources required to introduce HPV vaccination programs."
Hutubessy, who was an author on both papers, believes that the estimated costs of establishing a regional HPV vaccine program that delivers 3 doses of vaccine to girls at schools via phased national introduction in Tanzania can potentially pose financial and logistical challenges to the Ministry of Health of Tanzania. The estimates from both studies of US$9.76-12.40 per fully immunized girl, excluding vaccine costs, are higher than delivery costs of existing routine vaccination programs. At the same time he also believes that HPV vaccination programs will be more affordable and easier to implement in low resource settings compared to other preventive cervical cancer interventions such as population based screening programs. In addition, other studies have suggested that HPV vaccination at US$25 per fully-immunized girl would be very cost-effective in Eastern Africa.
Given the current challenges in achieving high coverage with cervical screening programmes in low income countries, HPV vaccination will be an important public health intervention for the prevention of cervical cancer. A further reduction in vaccine price and integration of HPV vaccination with other adolescent health interventions could improve the affordability and hence the cost-effectiveness of HPV vaccination programs, especially in low and middle income countries where the existing health systems are already stretched.
###
Notes
1. Costs of Delivering Human Papillomavirus Vaccination to School Girls in Mwanza Region, Tanzania
Wilm Quentin, Fern Terris-Prestholt, John Changalucha, Selephina Soteli, John W Edmunds, Raymond Hutubessy, David A Ross, Saidi Kapiga, Richard Hayes and Deborah Watson-Jones
BMC Medicine (in press)
Costing nationwide HPV vaccine delivery in Low and Middle Income Countries using the WHO Cervical Cancer Prevention and Control Costing Tool: A case study of The United Republic of Tanzania
Raymond Hutubessy, Ann Levin, Susan Wang, Winthrop Morgan, Mariam Ally, Nathalie Broutet and Theopista John
BMC Medicine (in press)
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
Article citation and URL available on request on the day of publication.
2. BMC Medicine is the flagship medical journal of the BMC series, publishing original research, commentaries and reviews that are either of significant interest to all areas of medicine and clinical practice, or provide key translational or clinical advances in a specific field. @BMCMedicine
3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector. @BioMedCentral
New studies shed light on what it cost to vaccinate girls against HPV in low income countries
2012-11-13
ELSE PRESS RELEASES FROM THIS DATE:
Awareness could eliminate inequalities in cancer diagnoses
2012-11-13
There are substantial inequalities in the stage at which cancer patients receive their diagnosis – a critical factor for cancer survival – a new study by the University of Cambridge reveals. The researchers found that age, sex and income as well as the type of cancer influenced the risk of a patient being diagnosed at an advanced stage of the disease. Eliminating these inequalities would help improve the chances of a cure for up to 5,600 patients with seven common cancers each year. The research was published today in the Annals of Oncology.
The scientists studied ten ...
On the hunt for rare cancer cells
2012-11-13
Tumor cells circulating in a patient's bloodstream can yield a great deal of information on how a tumor is responding to treatment and what drugs might be more effective against it. But first, these rare cells have to be captured and isolated from the many other cells found in a blood sample.
Many scientists are now working on microfluidic devices that can isolate circulating tumor cells (CTCs), but most of these have two major limitations: It takes too long to process a sufficient amount of blood, and there is no good way to extract cancer cells for analysis after their ...
Catch and release
2012-11-13
BOSTON, MA—A research team at Brigham and Women's Hospital has developed a novel device that may one day have broad therapeutic and diagnostic uses in the detection and capture of rare cell types, such as cancer cells, fetal cells, viruses and bacteria. The device is inspired by the long, elegant appendages of sea creatures, such as jellyfish and sea cucumbers.
The study will be published online on November 12, 2012 in Proceedings of the National Academy of Sciences.
The device, a microchip, is inspired by a jellyfish's long, sticky tentacles that are used to capture ...
Fasting time prior to blood lipid tests appears to have limited association with lipid levels
2012-11-13
CHICAGO – Fasting prior to blood lipid tests appears to have limited association with lipid subclass levels, suggesting that fasting for routine lipid level determinations may be unnecessary, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
"Although current guidelines recommend measuring lipid levels in a fasting state, recent studies suggest that nonfasting lipid profiles change minimally in response to food intake and may be superior to fasting levels in predicting adverse cardiovascular outcomes," write Davinder ...
Dance intervention improves self-rated health of girls with internalizing problems
2012-11-13
CHICAGO – A dance intervention program improved the self-rated health of Swedish girls with internalizing problems, such as stress and psychosomatic symptoms, according to a report of a study published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.
Exercise is considered a strategy to prevent and treat depression in school-aged youth and has been shown to promote positive feelings, enhance confidence to cope with problems, and increase confidence and self-control, the authors write in the study background.
Ann Duberg, R.P.T., ...
Study suggests L-DOPA therapy for Angelman syndrome may have both benefits and unanticipated effects
2012-11-13
CHAPEL HILL, N.C. – Last year a clinical trial of L-DOPA -- a mainstay of Parkinson's disease therapy -- was launched for Angelman syndrome, a rare intellectual disorder that shares similar motor symptoms such as tremors and difficulty with balance. The clinical trial is based on a 10-year-old case report showing benefit with the drug, but few studies since have explored the neurological justification for using L-DOPA to treat parkinsonian features in Angelman syndrome.
New research from the University of North Carolina School of Medicine, conducted in animal models ...
Gene sequencing project identifies abnormal gene that launches rare childhood leukemia
2012-11-13
Research led by the St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis.
The finding offers the first evidence of a mistake that gives rise to a significant percentage of acute megakaryoblastic leukemia (AMKL) cases in children. AMKL accounts for about 10 percent of pediatric acute myeloid leukemia (AML). The discovery paves the way for desperately needed treatment advances.
Investigators traced ...
UT Arlington physics team demonstrates new power generation technique
2012-11-13
A University of Texas at Arlington physics professor has helped create a hybrid nanomaterial that can be used to convert light and thermal energy into electrical current, surpassing earlier methods that used either light or thermal energy, but not both.
Working with Louisiana Tech University assistant professor Long Que, UT Arlington associate physics professor Wei Chen and graduate students Santana Bala Lakshmanan and Chang Yang synthesized a combination of copper sulfide nanoparticles and single-walled carbon nanotubes.
The team used the nanomaterial to build a prototype ...
Partisanship shapes beliefs about political and non-political issues
2012-11-13
A pre-election survey by the independent research organization NORC at the University of Chicago found that party affiliation alters how people react to political as well as non-political issues, including how individuals assess their own financial well-being.
The results suggest that partisanship is often a substitute for knowledge and personal experience, researchers said.
"We conducted this survey because the country is facing serious problems and solving them is made much harder by our deep partisan divide," said Kirk Wolter, senior fellow and executive vice president ...
Study offers new tool for incorporating water impacts into policy decisions
2012-11-13
MINNEAPOLIS / ST. PAUL (11/12/2012) —If you've eaten fish, gone for a boat ride or even taken a drink from the tap, you know clean water is a valuable commodity. But just how valuable? That's always been a tough question for policy makers to answer as they weigh the worth of clean water against societal needs that compromise it, such as the need to grow food or produce fossil fuels. Now, however, their ability to do so has been greatly enhanced by a new policy-making framework developed by a team of scientists led by Bonnie Keeler, research associate at the University of ...